STOCK TITAN

Inari Medical to Announce First Quarter 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Inari Medical, Inc. (NASDAQ: NARI) will announce its first quarter 2024 financial results on April 30, 2024. The company aims to transform the lives of patients with venous and other diseases. A conference call and webcast will be held to discuss the financial results and recent highlights.
Inari Medical, Inc. (NASDAQ: NARI) annuncerà i risultati finanziari del primo trimestre del 2024 il 30 aprile 2024. L'obiettivo dell'azienda è trasformare la vita dei pazienti affetti da malattie venose e altre patologie. Si terrà una conferenza telefonica e un webcast per discutere i risultati finanziari e gli ultimi sviluppi.
Inari Medical, Inc. (NASDAQ: NARI) anunciará los resultados financieros del primer trimestre de 2024 el 30 de abril de 2024. La compañía tiene como objetivo transformar las vidas de los pacientes con enfermedades venosas y otras enfermedades. Se realizará una llamada de conferencia y una transmisión web para discutir los resultados financieros y los últimos avances.
이나리 메디컬, Inc. (NASDAQ: NARI)은 2024년 4월 30일에 2024년 첫 분기 재무 결과를 발표할 예정입니다. 회사는 정맥 및 기타 질환을 가진 환자들의 삶을 변화시키는 것을 목표로 하고 있습니다. 재무 결과 및 최근 하이라이트에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트가 개최될 예정입니다.
Inari Medical, Inc. (NASDAQ : NARI) annoncera ses résultats financiers pour le premier trimestre 2024 le 30 avril 2024. L'entreprise vise à transformer la vie des patients souffrant de maladies veineuses et d'autres maladies. Une conférence téléphonique et une webdiffusion auront lieu pour discuter des résultats financiers et des faits saillants récents.
Inari Medical, Inc. (NASDAQ: NARI) wird am 30. April 2024 die Finanzergebnisse für das erste Quartal 2024 bekannt geben. Das Unternehmen zielt darauf ab, das Leben von Patienten mit venösen und anderen Krankheiten zu verändern. Es wird eine Telefonkonferenz und ein Webcast stattfinden, um die Finanzergebnisse und aktuelle Höhepunkte zu besprechen.
Positive
  • None.
Negative
  • None.

IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing 844-825-9789 for domestic callers or 412-317-5180 for international callers. The live webinar may be accessed by visiting the Events Section of the Inari investor relations website or by registering here. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Inari’s website.

About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous disease, including venous thromboembolism, chronic venous disease and beyond. We are just getting started. Learn more at www.inarimedical.com and connect with us on LinkedIn, X (Twitter), and Instagram.

Investor Contact:

John Hsu, CFA
VP, Investor Relations
949-658-3889
IR@inarimedical.com


FAQ

When will Inari Medical announce its first quarter 2024 financial results?

Inari Medical will announce its first quarter 2024 financial results on April 30, 2024.

What is the mission of Inari Medical, Inc.?

Inari Medical, Inc. aims to treat and transform the lives of patients suffering from venous and other diseases.

How can interested parties access the live call to discuss Inari's financial results?

Interested parties can access the live call by dialing 844-825-9789 for domestic callers or 412-317-5180 for international callers.

Where can a replay of the webinar be found?

A replay of the webinar will be available shortly after the call and will be archived on Inari's website.

Inari Medical, Inc.

NASDAQ:NARI

NARI Rankings

NARI Latest News

NARI Stock Data

2.41B
52.39M
9.55%
94.14%
6.89%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
IRVINE

About NARI

inari medical is a medical device company pioneering devices for the interventional treatment of vascular thrombi and emboli.